Horan Securities’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-302
Closed -$26.6K 426
2023
Q2
$26.6K Buy
302
+1
+0.3% +$86 0.01% 291
2023
Q1
$24.3K Buy
301
+12
+4% +$978 0.01% 282
2022
Q4
$22.4K Buy
289
+38
+15% +$3.08K 0.01% 282
2022
Q3
$20K Sell
251
-92
-27% -$8.27K 0.01% 266
2022
Q2
$30K Buy
343
+100
+41% +$10.1K 0.02% 226
2022
Q1
$27K Hold
243
0.02% 229
2021
Q4
$25K Buy
+243
New +$28.1K 0.01% 226
2021
Q2
$30K Hold
243
0.02% 207
2021
Q1
$29K Buy
243
+69
+40% +$8.09K 0.02% 188
2020
Q4
$20K Sell
174
-15
-8% -$1.65K 0.02% 196
2020
Q3
$20K Sell
189
-73
-28% -$7.33K 0.02% 165
2020
Q2
$24K Buy
262
+232
+773% +$22.2K 0.03% 113
2020
Q1
$3K Buy
+30
New +$3.19K ﹤0.01% 198
2019
Q4
Sell
-30
Closed -$3K 151
2019
Q3
$3K Buy
+30
New +$3.13K ﹤0.01% 220

Other funds holding MDT

Horan Securities's MDT Position: Q3 2023 in Review

Horan Securities sold out of Medtronic (MDT) in Q3 2023, closing a stake of 302 shares — an estimated $26.6K sold.

Horan Securities first reported a position in MDT in Q3 2019 and held it in 14 quarters. The position peaked at $30K in Q2 2022. 1,971 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

  • Horan Securities reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
  • Horan Securities sold 302 Medtronic shares in Q3 2023, an estimated $26.6K.
  • Horan Securities first reported a position in Medtronic in Q3 2019 and held it in 14 quarters.
  • Horan Securities's Medtronic position peaked at $30K in Q2 2022.
  • 1,971 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Horan Securities's 13F filing for Q3 2023, filed 1 Nov 2023.